糖尿病神经病变的全球市场 - 市场规模，占有率，成长分析:障碍，各流通管道，各类药物，产业预测(2022年～2028年)

Global Diabetic Neuropathy Market Size, Share, Growth Analysis, By Disorder(Peripheral Neuropathy, Autonomic Neuropathy), By Distribution channel(Hospitals, Clinics), By Drug Class(Anti-Depressants, Anti-Seizures) - Industry Forecast 2022-2028

出版日期: 2023年04月12日 | 出版商:

SkyQuest | 英文 165 Pages | 商品交期: 3-5个工作天内

价格

简介目录

全球糖尿病神经病变的市场规模在2021年估算为36亿2,638万美金，在预测期间(2023年～2030年)时预计将以6.9％的年复合成长率增长，从2022年的38亿7,660万美元成长到2030年70亿6,725万美元。

本报告提供全球糖尿病神经病变市场相关调查分析，提供市场动态及预测，市场区隔分别分析，企业简介等资讯。

竞争情形
Johnson & Johnson(美国)
Boehringer Ingelheim GmbH(德国)
NeuroMetrix, Inc(美国)
Eli Lilly and Company(美国)
GlaxoSmithKline plc(英国)
Lupin Limited(印度)
Pfizer Inc(美国)
Astellas Pharma Inc(日本)
Glenmark Pharmaceuticals Ltd(印度)
Arbor Pharmaceuticals, LLC(美国)
Depomed, Inc(美国)

简介目录

Product Code: SQSG35I2004

Global Diabetic Neuropathy Market size was valued at USD 3626.38 million in 2021 and is poised to grow from USD 3876.6 million in 2022 to USD 7067.25 million by 2030, growing at a CAGR of 6.9% in the forecast period (2023-2030).

Diabetic neuropathy is a disorder that affects the nerves and is linked to hyperglycemia. People who have had diabetes for a long time are more prone to have nerve damage throughout their bodies, even when the signs of diabetic neuropathies could not be identified at an early stage. In spite of the fact that diabetic neuropathy cannot be treated, it can be managed or prevented with the aid of a number of therapeutic techniques. Regulating bodies are required to approve more products and therapy techniques that are connected to the condition due to its intricacy. The high prevalence of diabetic neuropathy, which mostly affects diabetic people, will create several expansion opportunities for the companies operating in this industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetic Neuropathy Market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined by using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Segments covered in this report

The Global Diabetic Neuropathy Market segmentation is based on Disorder, Distribution Channel, and Region. Based on disorder the Diabetic Neuropathy Market is segmented into peripheral neuropathy, autonomic neuropathy, proximal neuropathy, and focal neuropathy. Based on distribution channels the Diabetic Neuropathy Market is segmented into hospitals, clinics, retail pharmacies, and online pharmacies. Based on region the global Diabetic Neuropathy market is segmented into North America, Europe, Asia-Pacific, Latin America, and MEA.

Driver

An increase in diabetic neuropathy demand due to an increase in diabetes prevalence.

The global demand for diabetic neuropathy will increase more slowly during the projection period due to the increased prevalence of diabetes. Furthermore, it's believed that some of the variables influencing the market's rise include obesity, coronary heart disease, diabetic neuropathy, and other sugar-related problems. Rising urbanisation, which encourages sedentary lifestyles like carbohydrate eating and low physical exercise, also has an impact on the market's expansion.

Expanding R&D efforts by major players to support the diabetic neuropathy market globally.

An rise in the older population and carbohydrate consumption are contributing to an increase in diabetes incidence. As the number of people with diabetes increases worldwide, there is an increasing need for therapies for diabetic neuropathy. The increased government spending to improve health services is also contributing to the market's expansion. Due to the rapid advancement of science and the rising expenditures made by the key industry participants, it is projected that the diabetic neuropathy market would expand in the near future.

Restraint

Expensive prescription drugs and alternative therapies restrain market expansion.

Among the obstacles to market expansion include the rising cost of diabetic neuropathy treatments, the widening selection of complementary therapies, and other factors. The availability of alternative therapies, such as radiotherapy and physical therapy, which are regarded as more comfortable and may offer patients satisfactory clinical outcomes, is one reason restricting the market's development. The strict regulations, product recalls, delays in Food and Drug Administration certifications, and other similar issues may further impede the growth of this industry.

Market Trends

In the upcoming year, high-tech products for better diabetic neuropathy treatment will be produced. Businesses are putting their efforts into developing talc, transdermal patches, and mouthwash, among other things. To address issues with surgical medicines, manufacturers have devised cutting-edge medication delivery technologies, such as syringe-free injection equipment. As a result, NFIT has generated a lot of interest in the disease's therapy, which is aiding the market's growth. Due to the growing need for innovative medication delivery techniques such oral, transdermal, parenteral, and inhalation, the market is growing.

Executive Summary

Market overview

Exhibit: Executive Summary - Chart on Market Overview
Exhibit: Executive Summary - Data Table on Market Overview
Exhibit: Executive Summary - Chart on Global Global Diabetic Neuropathy Market Characteristics
Exhibit: Executive Summary - Chart on Market by Geography
Exhibit: Executive Summary - Chart on Market Segmentation
Exhibit: Executive Summary - Chart on Incremental Growth
Exhibit: Executive Summary - Data Table on Incremental Growth
Exhibit: Executive Summary - Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

Market Dynamics
Exhibit: Impact analysis of DROC, 2021
Drivers
Opportunities
Restraints
Challenges
SWOT Analysis

KEY MARKET INSIGHTS

Technology Analysis
(Exhibit: Data Table: Name of technology and details)
Pricing Analysis
(Exhibit: Data Table: Name of technology and pricing details)
Supply Chain Analysis
(Exhibit: Detailed Supply Chain Presentation)
Value Chain Analysis
(Exhibit: Detailed Value Chain Presentation)
Ecosystem Of the Market
Exhibit: Parent Market Ecosystem Market Analysis
Exhibit: Market Characteristics of Parent Market
IP Analysis
(Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
Trade Analysis
(Exhibit: Data Table: Import and Export data details)
Startup Analysis
(Exhibit: Data Table: Emerging startups details)
Raw Material Analysis
(Exhibit: Data Table: Mapping of key raw materials)
Innovation Matrix
(Exhibit: Positioning Matrix: Mapping of new and existing technologies)
Pipeline product Analysis
(Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
Macroeconomic Indicators

COVID IMPACT

Introduction
Impact On Economy-scenario Assessment
Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
Revised Market Size
Exhibit: Data Table on Global Global Diabetic Neuropathy Market size and forecast 2021-2027 ($ million)
Impact Of COVID On Key Segments
Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
COVID Strategies By Company
Exhibit: Analysis on key strategies adopted by companies